Kappa Bioscience granted new patent of intermediaries used in synthesizing vitamin K2 MK-7
Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS - Balchem
Kappa Bioscience-supported study confirms correlation between low vitamin K status and more severe COVID-19 | Safic-Alcan : Specialty Chemicals Distributor | Innovative Formulations